Revenue
2011
2012
2013
2014
2015
2016
2017
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $6,000 | $23,000 | $0 | $13,000 | $109,000 | $250,000 | $743,000 |
| Research & development | — | — | — | — | — | — | — | — | — | — | $0 | $1,000 | $3,000 | $38,000 | $38,000 |
| Operating income | −$160,000 | −$59,000 | −$169,000 | −$159,000 | −$158,000 | −$165,000 | −$446,000 | −$178,000 | −$295,000 | −$572,000 | −$275,000 | −$313,000 | −$379,000 | −$412,000 | −$1.3M |
| EBITDAderived | — | — | — | — | — | — | — | — | — | −$571,000 | — | −$313,000 | −$374,000 | −$395,000 | −$1.1M |
| Net income | −$222,000 | −$113,000 | −$199,000 | −$173,000 | −$158,000 | −$163,000 | −$1.6M | −$445,000 | −$488,000 | −$741,000 | −$418,000 | −$443,000 | −$507,000 | −$554,000 | −$1.4M |
| Basic EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |